Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Invitae Acquires Three Companies: YouScript, Genelex, Diploid

Invitae Acquires Three Companies: YouScript, Genelex, Diploid

Mar 10, 2020
|
staff reporter

This article has been updated with additional information provided by Invitae executives during a conference call to discuss the acquisitions. 

NEW YORK – Invitae said after the close of the market on Tuesday that it is acquiring three companies: YouScript, Genelex, and Diploid.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letter Urges New Inquiry

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

Great Apes Get Shots, Too

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Woodcock on Vaccines, More

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

Science Paper Examines Molecular Contributors to Kidney Fibrosis

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.

What's Popular?

In Business News

  1. Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents

  2. Spatial Omics Firms Use AGBT as Launchpad for New Tech

    Premium

  3. Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

  4. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

  5. New Products Posted to GenomeWeb: Purigen Biosystems, Zymo Research, Qiagen, More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.